The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/11712
StudyName: Eligibility EARLY ACS Acute Coronary Syndrome NCT00089895
Date of export from the portal: 02.07.2020
Date of Upload / last change: 28.07.2015
License: Creative Commons BY 4.0

----

Description: 
The purpose of this study is to see if early INTEGRILIN® (eptifibatide) therapy in patients with non-ST-segment elevation acute coronary syndrome (ACS) reduces the occurence of death, heart attack and urgent cardiac intervention (surgery) compared to placebo (with delayed provisional use of eptifibatide).
https://clinicaltrials.gov/ct2/show/NCT00089895
